COVID-19 Booster: CD40.Pan.CoV Vaccine
We are testing a new vaccine to see if it safely boosts immunity in adults. This study will help us understand its effectiveness as a booster shot.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
University Hospital Of Clermont-Ferrand
CIC1405
Beaumont, France
Centre Hospitalier Universitaire De Caen Normandie
Centre de recherche clinique
Caen, France
CHU Henri Mondor
Service d'immunologie clinique et maladies infectieuses
Créteil, France
Sponsor: ANRS Maladies Infectieuses Emergentes
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.